APRIL WOLANEK: Open Payments
NPI 1518988542 · ARLINGTON, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$651 in 29 payments from 16 companies in 2025. Trend: 2023 $713 · 2024 $548 · 2025 $651
Food & beverage: $651
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $154 |
| AstraZeneca Pharmaceuticals LP | 5 | $113 |
| PFIZER INC. | 3 | $72 |
| Viatris Specialty LLC | 2 | $35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
| Abbott Laboratories | 1 | $29 |
| KYOWA KIRIN, INC. | 1 | $29 |
| Sage Therapeutics, LLC | 1 | $29 |
| Supernus Pharmaceuticals, Inc. | 1 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
Products named: Wegovy, YUPELRI, FARXIGA, JARDIANCE, PREVNAR 20, FREESTYLE LIBRE 3, CRYSVITA, ZURZUVAE.
Industry payments across WA — which companies pay providers there.
